Auto Owners Insurance Co Buys 455,504 Shares of CVS Health Corporation $CVS

Auto Owners Insurance Co grew its position in CVS Health Corporation (NYSE:CVS) by 8,052.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 461,161 shares of the pharmacy operator’s stock after purchasing an additional 455,504 shares during the period. Auto Owners Insurance Co’s holdings in CVS Health were worth $3,660,000 as of its most recent filing with the SEC.

A number of other large investors have also bought and sold shares of CVS. Caitong International Asset Management Co. Ltd lifted its holdings in CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 281 shares during the period. Swiss RE Ltd. acquired a new stake in CVS Health during the 4th quarter worth approximately $26,000. Sankala Group LLC bought a new position in CVS Health in the fourth quarter valued at approximately $28,000. Mcguire Capital Advisors Inc. acquired a new position in shares of CVS Health in the fourth quarter valued at approximately $28,000. Finally, Ares Financial Consulting LLC acquired a new position in shares of CVS Health in the fourth quarter valued at approximately $29,000. 80.66% of the stock is currently owned by institutional investors.

Insider Activity

In other news, EVP Tilak Mandadi sold 69,551 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the completion of the transaction, the executive vice president directly owned 10,133 shares of the company’s stock, valued at $907,714.14. This represents a 87.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Larry Robbins sold 370,462 shares of the company’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $93.45, for a total value of $34,619,673.90. Following the transaction, the director directly owned 4,824,799 shares in the company, valued at $450,877,466.55. This represents a 7.13% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 3,441,551 shares of company stock valued at $323,703,977. 0.85% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Truist Financial increased their target price on CVS Health from $102.00 to $108.00 and gave the stock a “buy” rating in a report on Monday, June 1st. Sanford C. Bernstein increased their price objective on CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a report on Tuesday, May 12th. Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, June 13th. UBS Group boosted their target price on CVS Health from $100.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, June 8th. Finally, Leerink Partners reaffirmed an “outperform” rating and set a $98.00 price target on shares of CVS Health in a research note on Thursday, March 5th. Twenty-two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $100.68.

CVS Health Trading Down 0.1%

CVS opened at $98.26 on Friday. CVS Health Corporation has a 1-year low of $58.50 and a 1-year high of $102.77. The company’s 50 day moving average is $89.31 and its 200-day moving average is $81.48. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78. The company has a market cap of $125.38 billion, a P/E ratio of 43.29, a PEG ratio of 0.96 and a beta of 0.62.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, beating analysts’ consensus estimates of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The business had revenue of $100.43 billion for the quarter, compared to analysts’ expectations of $94.99 billion. During the same quarter in the prior year, the firm posted $2.25 earnings per share. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Equities research analysts predict that CVS Health Corporation will post 7.44 earnings per share for the current fiscal year.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.